Relay Therapeutics, Inc. RLAY Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by Relay Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The official record: Relay Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Relay Therapeutics, Inc.'s total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Relay Therapeutics, Inc.'s total liabilities & equity?
- Relay Therapeutics, Inc. (RLAY) reported total liabilities & equity of $699.61M in Q1 2026.
- How has Relay Therapeutics, Inc.'s total liabilities & equity changed year-over-year?
- Relay Therapeutics, Inc.'s total liabilities & equity decreased by 12.5% year-over-year, from $799.36M to $699.61M.
- What is the long-term trend for Relay Therapeutics, Inc.'s total liabilities & equity?
- Over 5 years (2020 to 2025), Relay Therapeutics, Inc.'s total liabilities & equity has grown at a -4.9% compound annual growth rate (CAGR), from $799.83M to $621.33M.
- What does total liabilities & equity mean?
- Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.